Cell Lung Cancer?
Thomas J. Smith, MD, Associate Professor of Medicine and Health Administration Christopher E. Desch, MD, Associate Professor of Medicine and Health Administration Matthew David, Research Assistant, Massey Cancer Center, Virginia Commonwealth University, Medical College of Virginia Mark R. Somerfield, PhD, Director of Health Services Research, American Society of Clinical Oncology In 1985, a survey found that only about one-third of physicians and oncology nurses would have consented to chemotherapy for non-small-cell lung cancer. In response to statements made at a recent American Society of Oncology (ASCO) Board of Directors meeting questioning whether these data are still valid, Dr. Smith and colleagues conducted a new survey of oncologists attending a 1997 National Comprehensive Cancer Network (NCCN) annual meeting. The results of that survey are summarized and analyzed. Treatment recommendations for non-small-cell lung cancer[1-3] have changed markedly over the past 20 years, based
